romiplostim plus dexamethasone clinical trials

Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary Immune Thrombocytopenia

This study compares two treatments for newly diagnosed primary immune thrombocytopenia (ITP): romiplostim plus dexamethasone versus dexamethasone alone. Researchers want to see if combining these medicines works better at keeping platelet counts up and preventing bleeding over time.